HOME < SPECIALIZATION < HEALTH SCIENCES

SPECIALIZATION

Industry Specialization

Technology

Financial Services

Clean Technology

Health Sciences

Natural Resources

Real Estate


HEALTH SCIENCES SECTOR

Two equivalent forces - internal and external - are expected to generate both challenges and opportunities for the health sciences industry in 2009.

From an internal perspective, escalating health care costs will continue to be problematic for employers and individuals: Health debt is responsible for half of involuntary bankruptcies, and 1.5 million individuals are added to the ranks of the uninsured annually as employers drop health coverage.

External drivers will be evidenced by continued economic distress, government policy changes emanating from the 2008 elections, increased demands for transparency, and the integration of nontraditional players into the health care ecosystem.

We divide the health sciences industry into four main areas: pharmaceutical companies, health care services companies, products and devices providers, and biotechnology firms.

We use fundamental, bottom-up analysis that seeks to identify high-quality companies and the most compelling investment opportunities. In general, we follow a growth investment strategy, seeking companies whose earnings are expected to grow faster than inflation and the economy in general. When stock valuations seem unusually high, however, a “value” approach will be adhered to.

We also look for special situations that we believe could increase in value for a variety of reasons, including a change in management, an extraordinary corporate event, or a temporary imbalance in the supply of or demand for the securities.

Any opportunity we look at will pass our rigorous due diligence process led by our leading SME and through our overall RwE investment committee.

We assist our Health Sciences clients by offering:

  • Excellent basic and applied research in a supportive infrastructure
  • Seeking government commitments to R&D
  • Innovative financing solutions
  • Linking them to reliability and efficiency in clinical research
  • Advice on Government tariff-free access
  • A proven record of international collaborations
  • Advice on how to maximize Government R&D tax treatment
  • Advice on R&D and manufacturing
  • Insight into various funding alternatives.

 

About the Firm:

RwE Growth Partners, Inc. is a specialized group of seasoned professionals providing strategic and tactical assurance and advisory financial services, as well as capital, to firms in a select set of industries. We focus on “helping companies grow” by first understanding your current and projected needs and finding practical business and financial solutions.

If you need investment banking (capital, strategic Investment, M&A etc.) or assurance services (business valuation, fairness opinion etc) we can assist you to move forward and separate your firm from the crowd.

  RwE Growth Partners Inc.
Suite 2000-1066 W. Hastings Street
Vancouver, B.C.
V6E 3X2
eMail Contact info@rwegrowthpartners.com
Telephone Contact (778) 373-5432


All contents © All rights reserved. RwE Growth Partners, Inc.
Reproduction in whole or in part without prior written consent is strictly prohibited.
All trademarks are property of their legal owner.